Search
Search Constraints
You searched for: Author/Creator Toma, Azhar- Toma, Azhar [remove] 4
- 615.372 4
- Vaccines -- Periodicals 4
- AE adverse event -- CBER Center for Biologics Evaluation and Research -- CHMP Committee for Medical Products for Human Use -- CI confidence interval -- GMT geometric mean titers -- HA hemagglutinin -- HI hemagglutination-inhibition -- MGI mean geometric increase -- MN microneutralization -- pIMD potential immune-mediated disease -- PP per-protocol -- RBC red blood cells -- SAE serious adverse event -- SAS statistical analysis system -- SBIR internet-based randomization system -- SCR seroconversion rate -- SPR seroprotection rate -- TVC total vaccinated cohort -- VRR vaccine response rate 1
- AE adverse event -- CI confidence interval -- GMT geometric mean titers -- HA hemagglutinin -- HI hemagglutination inhibition -- MGI mean geometric increase -- MN microneutralization -- pIMD potential immune-mediated diseases -- PP per-protocol -- SAE serious adverse event -- SCR seroconversion rate -- SPR seroprotection rate -- VRR vaccine response rate 1
- H7N1 -- H7N9 -- Pandemic flu -- H7 influenza vaccine -- AS03 adjuvant 1
- H7N1 -- H7N9 -- Pandemic flu -- H7 influenza vaccine -- AS03 adjuvant -- Elderly population 1
- HZ herpes zoster -- RZV adjuvanted recombinant zoster vaccine -- VZV varicella-zoster virus -- gE VZV glycoprotein E -- AE adverse event -- SAE serious AE -- pIMD potential immune-mediated disease -- D day -- M month -- Y year -- YOA years of age -- ZOE-50/70 the pivotal RZV efficacy trials in adults ≥50/≥70 YOA -- MedDRA medical dictionary for regulatory activities -- SOC system organ class -- PT preferred term -- CI confidence interval -- RR relative risk -- AML acute myeloid leukemia 1
- Recombinant zoster vaccine -- Efficacy -- Herpes zoster -- Sex -- Region -- Geographic ancestry/ethnicity 1
- Varicella-zoster virus -- Vaccine -- Safety -- Reactogenicity 1